Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: J Virol Methods. 2013 Jun 19;193(2):270–277. doi: 10.1016/j.jviromet.2013.06.008

Figure 6. Efficacy of AAV2 in vivo across different brain areas.

Figure 6

To test efficacy of AAV2 in vivo, P0 or stereotaxic injection of mice was performed and expression of GFP was qualitatively evaluated four weeks post-injection. (A) Representative images of P0 injection of AAV2. Extensive spread of GFP fluorescence was observed in multiple brain regions, including (left to right) cortex, hippocampus, and cerebellum. Scale bars = 100 μM. (B) Representative images of stereotaxic injection of AAV2. GFP fluorescence was observed in all hippocampal regions. Image on right is more posterior. Scale bars = 500 μM. Data representative of three mice.